Is baricitinib tablets necessary for long-term use in the treatment of atopic dermatitis?

Whether baricitinib tablets need to be taken long-term when treating atopic dermatitis depends on multiple factors, including the severity of the patient's condition, individual response, and doctor's advice.

Baricitinib tablets are an oral selective JAK1 and JAK2 inhibitor that regulates the function of the immune system by inhibiting the activity of these enzymes, thereby reducing the secretion of inflammatory mediators and improving the symptoms of patients with atopic dermatitis. Multiple clinical studies have confirmed the effectiveness of baricitinib in the treatment of atopic dermatitis, particularly in improving itching and skin inflammation.

For patients with mild atopic dermatitis, if their symptoms are significantly controlled, they may not need to take baricitinib tablets for a long time. Under the guidance of a doctor, after a period of treatment, you can consider reducing the dose or discontinuing the drug. However, for patients with more severe cases, longer treatment may be needed to stabilize the condition due to severe skin inflammation and recurring symptoms. Such patients may need to take baricitinib tablets continuously for several months or even longer.

Every patient responds differently to medications. Some patients may be very sensitive to baricitinib tablets and be able to quickly control their symptoms, while others may require longer treatment to achieve the same effect. Therefore, whether long-term use of baricitinib tablets is needed depends on the patient’s individual response.

When deciding whether to take baricitinib long-term, it is most important to listen to your doctor's advice. Doctors will develop an individualized treatment plan based on the patient's specific circumstances, including severity of illness, individual response, and potential risks and side effects.

Although baricitinib tablets are excellent in treating atopic dermatitis, long-term use may cause some side effects. The most common side effects include liver function abnormalities, allergic reactions, headaches, upper respiratory tract infections, and nasopharyngitis. In addition, baricitinib tablets may increase the risk of leg vein thrombosis and pulmonary embolism. Therefore, when using baricitinib tablets for a long time, the patient's physical condition needs to be closely monitored and relevant examinations must be performed regularly to ensure the safety of the treatment.

References:

https://pdf.sciencedirectassets.com/272892/1-s2.0-S0190962222X00078/1-s2.0-S0190962222029838/am.pdf?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEAoaCXVzLWVhc3QtMSJIMEYCIQDOT8cFC5uv6b3H3B%2FVhIWYdH29nEUxn4DB4ASfQ5544AIhAJPpUvgu7O tMkmW5koiYm3M7Wp%2FYPw8BB49qYQTcMMbdKrwFCLP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQBRoMMDU5MDAzNTQ2ODY1IgxeO%2FZTPG9aVv8gZNEqkAVe kBs0ZNVZz9DUB1XacIegWZvDoz7E1kZwgP5pF%2FVOS3NJ5vsdbBWT2pyklQGigpMhgjNlUv5cRwpEq1hdOqjbmMVqKSummPt0J95B3sahLvRVHfceaDmJeM2z Uu8NcnoiO0uOF9xbvdghr%2FB8QJ8FAFoKu8R221xKD0%2Bo8bQDlX2fOM8LwzEF7R%2B3%2FpVP9UEer6wR8HuSDyubmpPRCuzqAj4Y31GQ46qkHs3eRqH2fL viAAQ7CNW5%2BNQfSaLEcJwkgpp3bskV1WCereCvHenpZoIWFDsYjg8PYUSiOCL3IeTSNgRpCpOyFzOrRMYgCxvN%2BIT18wpiVS8CwDCI7gsHwgXkyx26zwb Ms9ecQl7WyVR%2BqvHE2TJv5vcJKcua1M0%2FgC78VIhXaqnNOndwFX0Mn7u25daMaTSpDg%2BwpP2ycPEkXRu3ban5oUNHlvxnjocMF8G02X%2B%2FcXA8qVT en43cyXCVrUMJvVSfb4Wicundq0h%2BOK7YW8NlMFGlRivIPhmwuOiTjygevQvjmXUr5FM7q7cNx%2Fn%2FvLFGEYVPVYt3Y9ojN9r2xhWD0XzRJdQf9%2BDpf HyI6vLvh3RIJUCG8kZ3qCfmuF1HlKdXryjDTg2JK6B5dj5dqnnnre4Gb6q1PVhw9w1m9qsgthE1NrA%2FgZluw%2FQzVFUnZPP9vWr9ejEV1m5z%2FqbIUsgky QanlS7yBYPgo7HR2BPYSDxWEUxytDsuzYtjDa7eQMSU2L39krgdt9BY%2BVa6koteke3yl%2F5tUITnw1Xzvaz%2BWXcd%2BhRATRv2THakz5ZQsSlbjEBBP% 2FfjXl38mlG9ThZmJwClQdIQ28yX7r58VhcQgEkCp%2B4ufXyq6sfVwaHWqLieGUUt2iOSZzCGp7S6BjqwAal5OmgUtO46wfTWcEMVzUXlF209pCq6YHYcJ8cr GBjidaBtGBiLLe%2FdZXeKVSfVG1%2BwXIKeOkRXBZHN6CD8zcLuI03kK126zUzVEnyClEnkXQJMsixBb4ca2wXjPOLST6toNaCf6cJi59j0bYLlFieFiIOKZR txXz5M2OhmF3wqJQeDo9J562sGTvnBRFNDA4dXHS7xQuvtyExosrkLH7g0hzTtHkkMTIhY3eTo7iak&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Date =20241202T030132Z&X-Amz-SignedHeaders=host&X-Amz-Expires=300&X-Amz-Credential=ASIAQ3PHCVTYXU4WGNW3%2F20241202%2Fus-east-1 %2Fs3%2Faws4_request&X-Amz-Signature=b55dbdb4c217c6d7c4c349e876ee2ebace23096b7b614f7f31133908e4a3b244&hash=1b33442b0e06869 e7ca1638f80d76cfbdfcacd8a72e4c34a061c625988e8b850&host=68042c943591013ac2b2430a89b270f6af2c76d8dfd086a07176afe7c76c2c61π i=S0190962222029838&tid=pdf-5721e4a4-fa82-4328-9018-8aa648318745&sid=8ecb6cdc879f434ed388243668d58c9f26c8gxrqa&type=client